欧美综合天天夜夜久久_久久久精品人妻无码专区不卡_国产成人亚洲精品狼色在线_久久综合伊人 欧美日韩午夜一区二区,大地资源在线观看中文免费,久草热久草热线频97精品,亚洲精品电影久久久

About Us

Core Team

An experienced and efficient international team from China and the United States.
  1. Dr. Hongqi Tian

    Dr. Hongqi Tian

    Founder, Chairman, Chief Executive Officer

    Dr. Hongqi Tian, the founder of Kechow Pharma, has over twenty years of experience in new drug development. During his time at Array Biopharmaceuticals Inc. in the U.S., he successfully developed four new compounds into preclinical and clinical studies. In 2014, he founded Shanghai Kechow Pharma, Inc. The company’s new anti-cancer drug, HL-085, developed with 100% independent intellectual property rights, is regarded as the best of its kind in this field. It is currently undergoing Phase I/II clinical trials simultaneously in China and the U.S. In addition, the drug has applied for more than 80 patents worldwide, with over 40 granted, and has published 40 articles.

Meanwhile, Kechow Pharma has a comprehensive R&D team that integrates discovery, clinical development, and registration. This team works closely and seamlessly together with technical experts in medicinal chemistry, biology, medicine, registration, pharmacovigilance, project management, and more. From the discovery stage to the preclinical and clinical stages, the team brings extensive practical experience in their respective fields. Currently, our growing R&D team consists of nearly 80 scientists and staff based in Shanghai, Beijing, and Tianjin, as well as international clinical and regulatory offices in the United States. Through our U.S.-based international team, we have been able to rapidly expand our international clinical development and regulatory approval operations.